|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
7
|
|
pubmed:dateCreated |
2010-6-24
|
|
pubmed:abstractText |
To evaluate the activity and safety of nonpegylated liposomal doxorubicin (Myocet) when substituted for doxorubicin in the R-CHOP regimen (R-COMP).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
1569-8041
|
|
pubmed:author |
pubmed-author:BarbatoAA,
pubmed-author:BolognaSS,
pubmed-author:BrionesJJ,
pubmed-author:CaballeroDD,
pubmed-author:ChiappellaAA,
pubmed-author:DyerM J SMJ,
pubmed-author:FedericoMM,
pubmed-author:KayitalireLL,
pubmed-author:LuminariSS,
pubmed-author:MontaniniAA,
pubmed-author:NotterMM,
pubmed-author:PetriniMM
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
21
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1492-9
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:20007997-Aged,
pubmed-meshheading:20007997-Aged, 80 and over,
pubmed-meshheading:20007997-Antibodies, Monoclonal,
pubmed-meshheading:20007997-Antibodies, Monoclonal, Murine-Derived,
pubmed-meshheading:20007997-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:20007997-Cyclophosphamide,
pubmed-meshheading:20007997-Doxorubicin,
pubmed-meshheading:20007997-Female,
pubmed-meshheading:20007997-Humans,
pubmed-meshheading:20007997-Lymphoma, Large B-Cell, Diffuse,
pubmed-meshheading:20007997-Male,
pubmed-meshheading:20007997-Middle Aged,
pubmed-meshheading:20007997-Prednisone,
pubmed-meshheading:20007997-Prospective Studies,
pubmed-meshheading:20007997-Survival Rate,
pubmed-meshheading:20007997-Treatment Outcome,
pubmed-meshheading:20007997-Vincristine
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Nonpegylated liposomal doxorubicin (MyocetTM) combination (R-COMP) chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL): results from the phase II EUR018 trial.
|
|
pubmed:affiliation |
Department of Oncology and Haematology, University of Modena and Reggio Emilia, Modena, Italy.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Multicenter Study,
Clinical Trial, Phase II
|
